TVTX
Travere Therapeutics Inc

1,072
Mkt Cap
$3.17B
Volume
1.56M
52W High
$36.87
52W Low
$12.91
PE Ratio
-32.67
TVTX Fundamentals
Price
$34.73
Prev Close
$35.43
Open
$36.33
50D MA
$28.39
Beta
1.36
Avg. Volume
1.94M
EPS (Annual)
-$4.08
P/B
43.08
Rev/Employee
$605,649.35
Loading...
Loading...
News
all
press releases
Travere Therapeutics, Inc. (NASDAQ:TVTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seventeen brokerages that are covering the firm, Marketbeat Ratings...
MarketBeat·15h ago
News Placeholder
More News
News Placeholder
Travere Therapeutics (NASDAQ:TVTX) Sets New 1-Year High - Time to Buy?
Travere Therapeutics (NASDAQ:TVTX) Reaches New 52-Week High - Here's Why...
MarketBeat·1d ago
News Placeholder
Travere Therapeutics, Inc. $TVTX Shares Sold by Candriam S.C.A.
Candriam S.C.A. lessened its stake in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX - Free Report) by 4.0% during the second quarter, according to its most recent disclosure with the Securities...
MarketBeat·4d ago
News Placeholder
Atria Investments Inc Buys Shares of 10,417 Travere Therapeutics, Inc. $TVTX
Atria Investments Inc bought a new position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX - Free Report) during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
Zacks Research Downgrades Travere Therapeutics (NASDAQ:TVTX) to Hold
Zacks Research downgraded Travere Therapeutics from a "strong-buy" rating to a "hold" rating in a report on Wednesday...
MarketBeat·5d ago
News Placeholder
Travere Therapeutics, Inc. $TVTX Stock Holdings Lifted by Impax Asset Management Group plc
Impax Asset Management Group plc increased its holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX - Free Report) by 58.3% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
HC Wainwright Analysts Increase Earnings Estimates for TVTX
Travere Therapeutics, Inc. (NASDAQ:TVTX - Free Report) - Equities researchers at HC Wainwright boosted their FY2027 earnings per share estimates for Travere Therapeutics in a research report issued...
MarketBeat·7d ago
News Placeholder
Travere Therapeutics (NASDAQ:TVTX) Reaches New 1-Year High - Here's Why
Travere Therapeutics (NASDAQ:TVTX) Hits New 52-Week High - Time to Buy...
MarketBeat·8d ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Has $10.15 Million Holdings in Travere Therapeutics, Inc. $TVTX
Connor Clark & Lunn Investment Management Ltd. raised its position in Travere Therapeutics, Inc. (NASDAQ:TVTX - Free Report) by 38.4% during the 2nd quarter, according to its most recent filing with...
MarketBeat·9d ago
News Placeholder
S&CO Inc. Acquires New Holdings in Travere Therapeutics, Inc. $TVTX
S&CO Inc. bought a new position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·9d ago

Latest TVTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.